EPITHELIOID GRANULOMA-FORMATION BY A SYNTHETIC BACTERIAL-CELL WALL COMPONENT, MURAMYL DIPEPTIDE (MDP)
- 1 January 1980
- journal article
- research article
- Vol. 98 (3) , 733-747
Abstract
A synthetic muramyl dipeptide (MDP, N-acetylmuramyl-L-alanyl-D-isoglutamine) is a minimal essential structure that is contained generally in bacterial cell walls and is responsible for their many biologic activities such as adjuvant activity, pyrogenicity and a capacity to confer resistance against bacterial and viral infections. This MDP evoked dose-dependently massive organized epithelioid granulomas in guinea pigs when injected in the form of Freund-type water-in-oil emulsion. Granuloma formation reached a peak at 3 wk. A minimal effective dose of MDP was 0.1 .mu.g. Essentially no difference was observed qualitatively among granulomas evoked by MDP, MDP plus antigen and killed tubercle bacilli incorporated in the emulsion. Quantitatively, MDP was stronger in its granulomagenic capacity than tubercle bacilli. Antigenicity of MDP was not detectable. MDP may be a chemical structure in tubercle bacilli essential for epithelioid granuloma formation. The MDP-induced epithelioid granuloma may be of a non-allergic nature.This publication has 24 references indexed in Scilit:
- The Pyrogenicity of the Synthetic Adjuvant Muramyl Dipeptide and Two Structural AnaloguesThe Journal of Infectious Diseases, 1978
- The macrophage, target cell of the synthetic adjuvant muramyl dipeptideEuropean Journal of Immunology, 1978
- Inhibition of macrophage migration by synthetic muramyl dipeptideBiochemical and Biophysical Research Communications, 1978
- CUTANEOUS GRANULOMASInternational Journal of Dermatology, 1977
- Correlation of stereochemically specific structure in muramyl dipeptide between macrophage activation and adjuvant activityBiochemical and Biophysical Research Communications, 1977
- Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs.Proceedings of the National Academy of Sciences, 1977
- Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids.1975
- Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivativesBiochemical and Biophysical Research Communications, 1974
- The structure of mononuclear phagocytes differentiating in vivo. I. Sequential fine and histologic studies of the effect of Bacillus Calmette-Guerin (BCG).1974
- STUDIES ON ANTIBODY PRODUCTIONThe Journal of Experimental Medicine, 1955